| 17/07/26 | 17:00:00 | 17 Jul 2026 | | PDMR Notification RSU Vesting |
| 13/07/26 | 07:00:10 | 13 Jul 2026 | | PRTC: Celea Doses 1st Patient in Phase 3 IPF Trial |
| 09/07/26 | 07:00:04 | 9 Jul 2026 | | Director/PDMR Shareholding |
| 02/07/26 | 07:01:01 | 2 Jul 2026 | | PRTC Launches Celea w/ $180M & Top Tier Syndicate |
| 02/07/26 | 07:00:03 | 2 Jul 2026 | | PRTC Launches Celea: $180M & Asset Transfer |
| 10/06/26 | 17:38:37 | 10 Jun 2026 | | Result of AGM |
| 09/06/26 | 07:00:05 | 9 Jun 2026 | | PRTC's SPTX: New Positive GlyphAgo Ph1 Dosing Data |
| 04/06/26 | 17:37:04 | 4 Jun 2026 | | Holding(s) in Company |
| 29/05/26 | 17:00:01 | 29 May 2026 | | Holding(s) in Company |
| 27/05/26 | 17:30:00 | 27 May 2026 | | Holding(s) in Company |
| 22/05/26 | 17:00:01 | 22 May 2026 | | Holding(s) in Company |
| 15/05/26 | 07:00:06 | 15 May 2026 | | Correction - Holding(s) in Company |
| 13/05/26 | 12:00:01 | 13 May 2026 | | PRTC To Showcase Deupirfenidone at ATS Conference |
| 08/05/26 | 07:00:04 | 8 May 2026 | | Holding(s) in Company |
| 07/05/26 | 18:27:14 | 7 May 2026 | | Holding(s) in Company |
| 01/05/26 | 07:00:07 | 1 May 2026 | | PureTech's Seaport Prices Upsized IPO Nasdaq: SPTX |
| 29/04/26 | 07:01:00 | 29 Apr 2026 | | Final Results |
| 29/04/26 | 07:00:10 | 29 Apr 2026 | | PRTC Voluntarily Delists Nasdaq Depositary Shares |
| 27/04/26 | 18:09:15 | 27 Apr 2026 | | Holding(s) in Company |
| 27/04/26 | 12:05:00 | 27 Apr 2026 | | PRTC's Seaport Adds Neuropsychiatry Veteran to BOD |
| 24/04/26 | 17:58:40 | 24 Apr 2026 | | Holding(s) in Company |
| 22/04/26 | 12:00:00 | 22 Apr 2026 | | PRTC's Gallop: Positive Ph1 Topline MDS & AML Data |
| 16/04/26 | 17:00:00 | 16 Apr 2026 | | Holding(s) in Company |
| 16/04/26 | 07:00:07 | 16 Apr 2026 | | Holding(s) in Company |
| 13/04/26 | 07:05:00 | 13 Apr 2026 | | Notice of Results |
| 13/04/26 | 07:00:09 | 13 Apr 2026 | | PRTC's Seaport Files for Proposed Nasdaq IPO |
| 02/04/26 | 13:12:38 | 2 Apr 2026 | | PRTC Publishes Phase 2b Deupirfenidone IPF Results |
| 02/04/26 | 12:03:08 | 2 Apr 2026 | | PRTC's Seaport: Positive Topline Ph1 for GlyphAgo |
| 01/04/26 | 07:00:07 | 1 Apr 2026 | | Total Voting Rights |
| 25/03/26 | 18:00:48 | 25 Mar 2026 | | PRTC’s Seaport: GlyphAllo Paper Published |
| 13/03/26 | 16:35:00 | 13 Mar 2026 | | PDMR Notification RSU Vesting |
| 02/03/26 | 07:00:05 | 2 Mar 2026 | | Total Voting Rights |
| 25/02/26 | 07:00:10 | 25 Feb 2026 | | PRTC to Present at Leerink Healthcare Conference |
| 19/02/26 | 17:15:00 | 19 Feb 2026 | | PRTC's Deupirfenidone Granted FDA & EU ODD for IPF |
| 06/01/26 | 12:00:00 | 6 Jan 2026 | | PureTech to Present at the JP Morgan Conference |
| 18/12/25 | 07:00:08 | 18 Dec 2025 | | PureTech Appoints Robert Lyne as CEO |
| 10/12/25 | 17:41:29 | 10 Dec 2025 | | Results of AGM on June 16, 2025 – Update Statement |
| 10/12/25 | 17:30:00 | 10 Dec 2025 | | Holding(s) in Company |
| 08/12/25 | 07:00:11 | 8 Dec 2025 | | PRTC: Successful FDA Meeting; IPF Phase 3 in 1H26 |
| 05/12/25 | 18:00:00 | 5 Dec 2025 | | PRTC's Gallop: Positive Initial Topline AML Data |
| 18/11/25 | 17:30:00 | 18 Nov 2025 | | Holding(s) in Company |
| 07/11/25 | 18:18:30 | 7 Nov 2025 | | Holding(s) in Company |
| 03/11/25 | 14:00:00 | 3 Nov 2025 | | PRTC: New LYT-200 AML Data + Update at ASH |
| 22/10/25 | 07:00:10 | 22 Oct 2025 | | PRTC: New IPF Data Show Benefit in Older Patients |
| 17/10/25 | 17:30:00 | 17 Oct 2025 | | Holding(s) in Company |
| 14/10/25 | 07:00:14 | 14 Oct 2025 | | Holding(s) in Company |
| 10/10/25 | 17:59:20 | 10 Oct 2025 | | Holding(s) in Company |
| 09/10/25 | 18:10:45 | 9 Oct 2025 | | Holding(s) in Company |
| 01/10/25 | 07:00:16 | 1 Oct 2025 | | Holding(s) in Company |
| 29/09/25 | 07:00:18 | 29 Sept 2025 | | PRTC: New IPF Data Show Switch Patients Stabilized |
